AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gliclapack-M Tablet SR

Prescription Icon
Prescription Required

Marketer

Koye Pharmaceuticals Pvt ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Gliclapack-M Tablet SR

Diabex Duo SR tablets are classified as antidiabetic medications, a dual-drug formulation for managing type 2 diabetes in adults. This medication aids in regulating blood glucose levels. Diabex Duo SR should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, potentially causing kidney complications, vision loss, neuropathy, and limb impairment. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation, and vomiting. Knowing hypoglycemia symptoms and treatment—carrying a fast-acting glucose source like sugary snacks or juice—is essential. Alcohol consumption elevates hypoglycemia risk and should be limited. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe liver or kidney disease. Prior heart conditions should be disclosed to your physician before commencing treatment. Its suitability for pregnant or breastfeeding women requires medical consultation. Regular blood glucose monitoring, along with blood cell and liver function tests as deemed necessary by your physician, are recommended.

Uses of Gliclapack-M Tablet SR

Adult-onset diabetes

Major Benefits of Gliclapack-M Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Gliclapack-M SR tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with food.

Common Side effects of Gliclapack-M Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Gliclapack-M Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Gliclapack-M Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Gliclapack-M Tablet SR works:

Gliclazide and Metformin are combined in the sustained-release Gliclapack-M Tablet SR to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Gliclapack-M SR tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Gliclapack-M tablets are contraindicated in pregnancy due to established fetal risk. In exceptional, life-threatening circumstances, a physician might prescribe them if the potential benefits outweigh the known hazards. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Sustained-release Gliclapack-M tablets should likely be avoided while breastfeeding. Preliminary human evidence indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Gliclapack-M SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Gliclapack-M SR tablet use. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Gliclapack-M Tablet SR cautiously, potentially requiring dose modification. A physician's consultation is advised. Low initial doses are typically prescribed for those with mild to moderate liver disease; however, it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Gliclapack-M Tablet SR :

Should you forget a Gliclapack-M Tablet SR dose, administer it at your earliest convenience. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gliclapack-M Tablet SR

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Gliclapack-M Tablet SR

Gliclapack-M SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's unsuitable for type 1 diabetes.
Gliclapack-M Tablet SR commonly causes side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, may also occur. Prolonged use can result in vitamin B12 deficiency.
Gliclapack-M Tablet SR can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Gliclapack-M Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Gliclapack-M Tablet SR and seek immediate medical attention.
Prolonged Gliclapack-M Tablet SR use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Gliclapack-M Tablet SR is contraindicated in patients with allergies to its components or excipients, and in those with moderate-to-severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Consuming alcohol while taking Gliclapack-M Tablet SR is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Gliclapack-M SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Gliclapack-M Tablet SR commonly causes side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Gliclapack-M Tablet SR can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Gliclapack-M Tablet SR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Gliclapack-M Tablet SR and seek immediate medical attention.
Prolonged Gliclapack-M Tablet SR use can lead to vitamin B12 deficiency by impairing its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 intake, at least annually, is recommended by some researchers.
Gliclapack-M Tablet SR is contraindicated in patients with hypersensitivity to any of its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Consuming alcohol while taking Gliclapack-M Tablet SR is unsafe. This combination may cause dangerously low blood sugar and raise the risk of lactic acidosis.
Gliclapack-M Tablet SR
84
MRP 102
17% off